Fellow
Dr. Yu YU
founder and CEO of pleryon therapeutics
Dr. Yu is the founder and CEO of Pleryon Therapeutic. He has over 16 years of experience in interdisciplinary biomaterials R&D. He has led various polymer-based pharmaceutical and medical device projects in diverse therapeutic areas. As a proliferated inventor, he has filed more than 30 issued or pending patents. He has also published over 13 articles in peer review journals and has been cited for over 500 times. Dr. Yu received his BSc in Biology and PhD in Bioengineering from the Hong Kong University of Science and Technology (HKUST).
Company Description
Pleryon Therapeutics is a preclinical stage biotech startup company. Our mission is to develop novel polymer-based therapeutics to address global unmet medical needs related to aging. Since its formal operation in 2020, Pleryon has raised closed to RMB 100 million from top biotech private investors in China. Pleryon is advancing its diverse pipelines in multiple disease areas, including ophthalmology, orthopedics, and tissue regeneration.